Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TQB2922 in Advanced Cancers
NCT07260708Phase 1Recruiting
- Sponsor
- Chia Tai Tianqing
- Start
- Dec 2025
- Primary completion
- Dec 2029
- Modality
- Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs)
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tqb2922 in Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC), sponsored by Chia Tai Tianqing. Primary endpoints: Time to Peak Concentration, Peak concentration and 8 more. Started Dec 2025; status: recruiting.
02
Drugs
tqb2922
03
Conditions
Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC)
Beyond the preview
Go deeper on NCT07260708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07260708.